Conquering Diseases

Study Of An Investigational Drug Combination For Metastatic Non-Small Cell Lung Cancer

Description

Seeking men and women whose metastatic non-small lung cancer (NSCLC) has progressed after platinum doublet chemotherapy and immunotherapy for a study of an investigational drug combination.

Overview

We are studying how an investigational drug combination compares to the standard chemotherapy for metastatic non-small cell lung cancer (NSCLC). Participants in this study will be randomly assigned to one of three groups. One group will get the investigational drug combination, one group will get the standard chemotherapy and one group will get only one of the investigational drugs.

What we're hoping for

We hope to evaluate how safely and well an experimental drug combination works compared to the standard chemotherapy for metastatic non-small cell lung cancer (NSCLC)

Additional Information

ClinicalTrials.gov Identifier: NCT03976375

 Principal Investigator

Nahida  Islam, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989